To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene BRD7TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
405 supporting clones for gene BRD7 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CR593793 placenta .a 1 to 2261 1 to 2261 exact tiling clone,   2261/2261
(100 %)
0 diff
(100 %id)
NM_013263.4   .a 1 to 2309 1 to 2309 exact RefSeq, AAA   2309/2309
(100 %)
0 diff
(100 %id)
AJ271881 fetal brain .a 46 to 2234 4 to 2193   AAA   2190/2193
(99 %)
8 diff
(99.7 %id)
AF152604   .a 108 to 2296 1 to 2189   tiling clone, AAA   2189/2189
(100 %)
1 diff
(100.0 %id)
AK074613 whole embryo, mainly body .a 864 to 2296 1 to 1433   available from FLJ, AAA   1433/1433
(100 %)
0 diff
(100 %id)
DA572109 whole embryo, mainly body .a 865 to 1739 2 to 867   capped   866/879
(98 %)
17 diff
(98.1 %id)
BQ690436 ductal carcinoma, cell line, Pancreas .a 988 to 1772 9 to 802       791/896
(88 %)
22 diff
(97.6 %id)
DR158750 human embryonic stem cells differentiated toan early endodermal cell type .a 1019 to 1790 1 to 772       772/772
(100 %)
2 diff
(99.8 %id)
AK027308 whole embryo, mainly head .a 1030 to 2235 1 to 1206   available from FLJ,   1206/1206
(100 %)
1 diff
(100.0 %id)
DA569931 whole embryo, mainly head .a 1031 to 1740 2 to 712   fully sequenced, capped   711/711
(100 %)
2 diff
(99.8 %id)
DT219124 brain .a 1076 to 1731 1 to 656       656/656
(100 %)
0 diff
(100 %id)
BU786302 Pancreas, Purified pancreatic islet .a 1082 to 1684 1 to 603       603/603
(100 %)
3 diff
(99.6 %id)
BU188286 melanotic melanoma, skin .a 1096 to 1962 1 to 878       878/879
(99 %)
15 diff
(98.3 %id)
CN304472 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1134 to 1836 1 to 703       703/703
(100 %)
0 diff
(100 %id)
BX422511 fetal liver, Liver .a 1186 to 2183 1014 to 24       991/1019
(97 %)
31 diff
(97.0 %id)
CF128894 Chondrosarcoma Lung Metastasis cell lines, lung .a 1205 to 1916 1 to 709       709/713
(99 %)
9 diff
(98.8 %id)
TI_154189046   .a 1205 to 2058 51 to 897   AAA   847/975
(86 %)
16 diff
(98.4 %id)
CR989157 T-Lymphocytes .a 1237 to 2125 1 to 889       889/889
(100 %)
3 diff
(99.7 %id)
AA292166 ovarian tumor, ovary .a 1289 to 1805 1 to 517       517/517
(100 %)
0 diff
(100 %id)
TI_44343567   .a 1297 to 1937 77 to 717       641/717
(89 %)
7 diff
(99.1 %id)
BI667608 brain, hypothalamus .a 1302 to 1937 1 to 635       635/635
(100 %)
6 diff
(99.1 %id)
DB505708 hypothalamus .a 1307 to 1736 1 to 434       434/435
(99 %)
13 diff
(97.1 %id)
BE876466 large cell carcinoma, undifferentiated, lung .a 1324 to 2060 1 to 736       736/755
(97 %)
11 diff
(98.6 %id)
BX438794 placenta .a 1353 to 2261 909 to 1       909/909
(100 %)
5 diff
(99.5 %id)
AA234135 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1405 to 1826 1 to 421   fully sequenced,   421/421
(100 %)
1 diff
(99.8 %id)
AA286979 germinal center B cell .a 1438 to 1939 1 to 500       500/500
(100 %)
2 diff
(99.6 %id)
TI_153952968   .a 1470 to 1874 64 to 470   fully sequenced,   407/407
(100 %)
3 diff
(99.3 %id)
BQ231832 melanotic melanoma, skin .a 1484 to 2226 1 to 749       749/913
(82 %)
9 diff
(99.1 %id)
BY797899 eye .a 1488 to 2121 1 to 634       634/634
(100 %)
0 diff
(100 %id)
TI_149311775   .a 1489 to 2289 891 to 100   AAA   792/946
(83 %)
9 diff
(99.1 %id)
BX453831 placenta .a 1490 to 2214 724 to 1       724/848
(85 %)
35 diff
(95.9 %id)
BU596542 mixed (pool of 40 RNAs) .a 1496 to 2297 1 to 815       815/817
(99 %)
22 diff
(97.4 %id)
TI_154030377   .a 1498 to 2296 874 to 87   AAA   788/945
(83 %)
17 diff
(98.3 %id)
CN304475 embryonic stem cells, DMSO-treated H9 cellline .a 1500 to 2145 1 to 647       647/649
(99 %)
4 diff
(99.4 %id)
BU690103 Human Lung Epithelial cells, lung .a 1503 to 2235 744 to 19   AAA   726/730
(99 %)
9 diff
(98.8 %id)
BU631142 cell lines, Chondrosarcoma .a 1508 to 2235 740 to 19   AAA   722/732
(98 %)
7 diff
(99.1 %id)
BM977539 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 1516 to 2289 787 to 19   AAA   769/773
(99 %)
5 diff
(99.4 %id)
BU628841 Bone, Enchondroma cell line .a 1518 to 2289 786 to 19   AAA   768/768
(100 %)
9 diff
(98.9 %id)
BU620378 cell lines, Chondrosarcoma .a 1523 to 2235 726 to 19   AAA   708/711
(99 %)
5 diff
(99.3 %id)
AI885109 anaplastic oligodendroglioma, brain .a 1538 to 2235 698 to 1       698/698
(100 %)
11 diff
(98.5 %id)
W31333.
matches multiple genes
lung .a 1545 to 2008 1 to 474     also hits gene ERH 474/475
(99 %)
13 diff
(97.3 %id)
BM992830 lung, Metastatic Chondrosarcoma .a 1560 to 2235 691 to 19   AAA   673/676
(99 %)
4 diff
(99.5 %id)
CA437083 lung, Metastatic Chondrosarcoma .a 1575 to 2235 679 to 19   AAA   661/661
(100 %)
0 diff
(100 %id)
AI858343 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 1579 to 2235 657 to 1       657/657
(100 %)
8 diff
(98.8 %id)
AW376396 colon .a 1581 to 1713 1 to 132       132/132
(100 %)
8 diff
(94.0 %id)
BQ775186 Bone, Human Chondrosarcoma Cell Line .a 1583 to 2235 671 to 19   AAA   653/653
(100 %)
0 diff
(100 %id)
CA442476 Fibrosarcoma .a 1588 to 2296 726 to 19   AAA   708/708
(100 %)
3 diff
(99.6 %id)
BF589748 sciatic nerve .a 1589 to 2195 608 to 2       607/608
(99 %)
0 diff
(100 %id)
CA312503 Human Lung Epithelial cells, lung .a 1590 to 2296 725 to 19   AAA   707/707
(100 %)
2 diff
(99.8 %id)
BU623951 cell lines, Enchondroma .a 1621 to 2289 687 to 19   AAA   669/675
(99 %)
0 diff
(100 %id)
BM669874.
matches multiple genes
eye, fetal eyes .a 1627 to 2235 627 to 19   AAA also hits gene BRD7P2 609/609
(100 %)
0 diff
(100 %id)
AW276341 lung, two pooled squamous cell carcinomas .a 1640 to 2237 605 to 8       598/605
(98 %)
1 diff
(99.9 %id)
DB356644 whole embryo, mainly head .a 1710 to 2235 525 to 1   fully sequenced,   525/525
(100 %)
2 diff
(99.7 %id)
DB359070 whole embryo, mainly body .a 1773 to 2296 523 to 1       523/552
(94 %)
12 diff
(97.9 %id)
AA235012 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1796 to 2235 440 to 1   fully sequenced,   440/440
(100 %)
0 diff
(100 %id)
TI_151697435   .a 1844 to 2235 513 to 122   fully sequenced, AAA   392/392
(100 %)
10 diff
(97.5 %id)
AA292066 ovarian tumor, ovary .a 1970 to 2295 362 to 37   AAA   326/326
(100 %)
0 diff
(100 %id)
BX438795 placenta .b 1 to 866 1 to 865       865/865
(100 %)
3 diff
(99.7 %id)
BX377622 Placenta Cot 25-normalized .b 1 to 987 1 to 984   tiling clone,   984/984
(100 %)
3 diff
(99.7 %id)
BX422512 fetal liver, Liver .b 1 to 1014 1 to 1012   tiling clone,   1012/1081
(93 %)
36 diff
(96.7 %id)
NM_001173984.2   .b 1 to 2312 1 to 2312 exact RefSeq, AAA   2312/2312
(100 %)
0 diff
(100 %id)
DA645362   .b 102 to 683 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
CR997680 T-Lymphocytes .b 124 to 978 1 to 855       855/860
(99 %)
1 diff
(99.9 %id)
W22276 eye, retina .b 124 to 594 478 to 12       467/487
(95 %)
18 diff
(96.4 %id)
DN994616 brain, whole brain .b 145 to 685 24 to 564       541/564
(95 %)
6 diff
(99.0 %id)
CD689127 normal nasopharynx .b 151 to 710 17 to 576       560/576
(97 %)
6 diff
(99.0 %id)
AF213969   .b 156 to 2292 1 to 2137 R66G R83T R96Q tiling clone,   2137/2137
(100 %)
3 diff
(99.9 %id)
DA020465   .b 156 to 739 2 to 586   capped   585/585
(100 %)
1 diff
(99.9 %id)
BP271963   .b 156 to 747 1 to 592       592/592
(100 %)
7 diff
(98.9 %id)
BP284660 bone marrow .b 157 to 738 1 to 584       584/587
(99 %)
4 diff
(99.4 %id)
DA718955   .b 158 to 741 2 to 586   capped   585/585
(100 %)
3 diff
(99.5 %id)
EL734724 mixed .b 161 to 783 1 to 623       623/623
(100 %)
2 diff
(99.7 %id)
EH345471   .b 174 to 246 1 to 73       73/75
(97 %)
1 diff
(98.7 %id)
CN304471 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 178 to 912 12 to 746       735/746
(98 %)
6 diff
(99.2 %id)
BQ675701 epidermoid carcinoma, cell line, salivary gland .b 188 to 955 1 to 770   AAA   770/859
(89 %)
7 diff
(99.2 %id)
BF813162 colon_ins .b 190 to 723 1 to 534       534/534
(100 %)
2 diff
(99.7 %id)
BI554257 anaplastic oligodendroglioma with 1p/19qloss, brain .b 195 to 969 1 to 777       777/799
(97 %)
12 diff
(98.5 %id)
TI_44384960   .b 195 to 969 55 to 831       777/799
(97 %)
12 diff
(98.5 %id)
AA248293   .b 213 to 570 1 to 359       357/359
(99 %)
6 diff
(98.4 %id)
BQ650676 hepatocellular carcinoma, cell line, Liver .b 223 to 828 10 to 619       610/801
(76 %)
19 diff
(97.7 %id)
AF152605 nasopharyngeal carcinoma .b 229 to 323 1 to 95       95/95
(100 %)
5 diff
(94.8 %id)
CF552375 Pooled muscle (cardiac and skeletal) .b 287 to 1156 1 to 876       876/881
(99 %)
10 diff
(98.9 %id)
DB000442.
matches multiple genes
breast, tumor tissue .b 290 to 800 35 to 545   capped also hits gene BRD7P2 511/544
(93 %)
6 diff
(98.9 %id)
AA318229 retina .b 321 to 624 1 to 304       304/304
(100 %)
2 diff
(99.4 %id)
AA384048 thyroid gland .b 326 to 581 1 to 257       257/257
(100 %)
1 diff
(99.7 %id)
BI438974 Pancreas, Purified pancreatic islet .b 333 to 943 1 to 611       611/611
(100 %)
3 diff
(99.6 %id)
BE925257 amnion_normal .b 341 to 600 9 to 267       259/279
(92 %)
9 diff
(96.8 %id)
AA247891   .b 351 to 600 1 to 250       250/254
(98 %)
7 diff
(97.3 %id)
AA093126   .b 357 to 666 1 to 289       292/305
(95 %)
24 diff
(92.2 %id)
AA488567   .b 360 to 884 1 to 525       525/525
(100 %)
0 diff
(100 %id)
DA833649 placenta .b 365 to 1045 2 to 684   capped   683/687
(99 %)
4 diff
(99.5 %id)
BE183440 head_neck .b 369 to 799 429 to 1     Submitted on the opposite strand 429/429
(100 %)
6 diff
(98.7 %id)
CN304468 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 375 to 1102 1 to 729       729/729
(100 %)
2 diff
(99.8 %id)
EB386413 eye, optic nerve .b 383 to 1176 1 to 794       794/794
(100 %)
1 diff
(99.9 %id)
BM985285 lung .b 389 to 1051 663 to 1       663/663
(100 %)
4 diff
(99.4 %id)
CA419673 Bone, Human Chondrosarcoma Cell Line .b 390 to 967 35 to 612     Submitted on the opposite strand 578/594
(97 %)
8 diff
(98.7 %id)
AW369759.
matches multiple genes
breast .b 397 to 881 107 to 590     also hits gene BRD7P2 484/592
(81 %)
10 diff
(98.4 %id)
AW369764 breast .b 397 to 894 127 to 624       498/624
(79 %)
7 diff
(98.9 %id)
BM466021 embryonal carcinoma, cell line, testis .b 398 to 1489 1 to 1091       1091/1096
(99 %)
43 diff
(96.1 %id)
AI674162 Prostate .b 400 to 1034 634 to 1       634/643
(98 %)
2 diff
(99.7 %id)
AI632542 pooled germ cell tumors .b 414 to 1033 620 to 1       620/636
(97 %)
11 diff
(98.3 %id)
BM008582 adenocarcinoma, Pancreas .b 414 to 1051 1 to 639   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 639/639
(100 %)
7 diff
(99.0 %id)
TI_59386285   .b 415 to 1051 105 to 742   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 638/1022
(62 %)
6 diff
(99.5 %id)
BM909043 astrocytoma grade IV, cell line, brain .b 419 to 1046 1 to 629       629/1162
(54 %)
7 diff
(99.4 %id)
TI_149275714   .b 445 to 1053 676 to 65   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 612/1044
(58 %)
10 diff
(99.1 %id)
BI438648 Pancreas, Purified pancreatic islet .b 455 to 1033 579 to 1       579/579
(100 %)
0 diff
(100 %id)
CN304473 embryonic stem cells, DMSO-treated H9 cellline .b 460 to 1041 1 to 582   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 582/584
(99 %)
3 diff
(99.5 %id)
BU678899 lung, Primary Lung Epithelial Cells .b 462 to 1051 590 to 1       590/590
(100 %)
6 diff
(99.0 %id)
BG031737 breast, mammary adenocarcinoma, cell line .b 465 to 1244 1 to 779       779/943
(82 %)
17 diff
(98.2 %id)
BF872678 lung_tumor .b 479 to 948 470 to 1     Submitted on the opposite strand 470/470
(100 %)
0 diff
(100 %id)
CU453221 epidermis .b 483 to 1171 727 to 39     Submitted on the opposite strand 689/727
(94 %)
0 diff
(100 %id)
AW401944 lymph .b 484 to 978 8 to 502       495/502
(98 %)
9 diff
(98.3 %id)
BM460725 leiomyosarcoma, uterus .b 484 to 1488 1 to 1017       1015/1065
(95 %)
29 diff
(97.3 %id)
TI_154138130   .b 484 to 1075 79 to 672       594/594
(100 %)
8 diff
(98.7 %id)
BE552152 Kidney .b 491 to 1034 545 to 1       545/545
(100 %)
6 diff
(98.9 %id)
BF063666 colon, colon tumor, RER+ .b 496 to 1032 537 to 1       537/537
(100 %)
9 diff
(98.4 %id)
CA419771 Bone, Human Chondrosarcoma Cell Line .b 503 to 912 203 to 612     Submitted on the opposite strand 410/595
(68 %)
8 diff
(98.7 %id)
BE934184 head_neck .b 510 to 657 150 to 5       146/150
(97 %)
0 diff
(100 %id)
EC568023 Prostate .b 515 to 601 18 to 104       87/104
(83 %)
5 diff
(95.2 %id)
BQ433845 embryonal carcinoma, cell line, testis .b 517 to 1355 1 to 843       843/859
(98 %)
8 diff
(99.1 %id)
BQ011423 placenta .b 520 to 1051 532 to 1       532/532
(100 %)
4 diff
(99.3 %id)
AI492233 B-cell, chronic lymphotic leukemia .b 537 to 1036 503 to 4       500/503
(99 %)
0 diff
(100 %id)
BE207935 muscle, rhabdomyosarcoma .b 539 to 1035 497 to 1       497/497
(100 %)
0 diff
(100 %id)
BE207956 muscle, rhabdomyosarcoma .b 551 to 1035 485 to 1       485/485
(100 %)
2 diff
(99.6 %id)
BE858294 Prostate .b 551 to 1031 481 to 1       481/664
(72 %)
19 diff
(97.2 %id)
DB230954 trachea .b 552 to 1034 2 to 484   capped   483/483
(100 %)
0 diff
(100 %id)
BE531153 adenocarcinoma, Pancreas .b 554 to 1307 1 to 754       754/861
(87 %)
8 diff
(99.1 %id)
DA787146 brain .b 554 to 1009 2 to 460   capped   459/459
(100 %)
4 diff
(99.2 %id)
CF134920 CNCAP(3)T-225 cell line, Prostate .b 570 to 1022 1 to 453       453/453
(100 %)
4 diff
(99.2 %id)
TI_154163061   .b 577 to 1246 81 to 752       672/729
(92 %)
10 diff
(98.7 %id)
AI080665 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 581 to 1033 453 to 1       453/453
(100 %)
0 diff
(100 %id)
DA363004 subthalamic nucleus .b 589 to 1146 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
BQ752507 Prostate .b 594 to 1036 451 to 9   AAA Submitted on the opposite strand 443/451
(98 %)
1 diff
(99.8 %id)
BU676768 lung, Primary Lung Epithelial Cells .b 594 to 1051 459 to 1       459/459
(100 %)
0 diff
(100 %id)
AA134191.
matches multiple genes
  .b 596 to 1005 410 to 1     also hits gene BRD7P2 410/410
(100 %)
0 diff
(100 %id)
BQ686403 ductal carcinoma, cell line, Pancreas .b 629 to 1052 1 to 424   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 424/424
(100 %)
4 diff
(99.1 %id)
BG291422 bladder, transitional cell papilloma, cell line .b 637 to 1186 34 to 583       550/583
(94 %)
0 diff
(100 %id)
AW173688 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 645 to 1032 388 to 1       388/388
(100 %)
1 diff
(99.8 %id)
BE218396 carcinoid, lung .b 647 to 1031 385 to 1       385/385
(100 %)
8 diff
(98.0 %id)
BQ340150 nervous_normal .b 652 to 1247 611 to 16       596/611
(97 %)
12 diff
(98.1 %id)
AI825203 pooled germ cell tumors .b 663 to 1038 378 to 1       378/378
(100 %)
2 diff
(99.5 %id)
AA903753 pooled germ cell tumors .b 674 to 1038 363 to 1       363/363
(100 %)
2 diff
(99.5 %id)
DA848716 placenta .b 677 to 1247 2 to 572   capped   571/580
(98 %)
0 diff
(100 %id)
BG118136 adenocarcinoma, cell line, Liver .b 682 to 1425 1 to 742       742/948
(78 %)
20 diff
(97.9 %id)
BX408934 placenta .b 704 to 1482 777 to 1       777/893
(87 %)
18 diff
(98.0 %id)
BQ673940 epidermoid carcinoma, cell line, salivary gland .b 707 to 1488 37 to 821       785/926
(84 %)
26 diff
(97.2 %id)
CV569549 cornea, eye .b 709 to 1302 1 to 594       594/594
(100 %)
0 diff
(100 %id)
AW004710 colon .b 711 to 1036 326 to 1       326/326
(100 %)
0 diff
(100 %id)
AA535430 colon .b 712 to 1033 322 to 1       322/322
(100 %)
6 diff
(98.2 %id)
BP267632 thyroid .b 713 to 1296 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
AA887701 colon, colon tumor RER+ .b 728 to 1033 306 to 1       306/306
(100 %)
2 diff
(99.4 %id)
BE817578 breast_normal .b 746 to 1051 28 to 339       312/341
(91 %)
12 diff
(96.5 %id)
BQ312025 breast_normal .b 766 to 1129 57 to 424       368/424
(86 %)
19 diff
(95.6 %id)
CN304474 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 784 to 1380 1 to 596       596/596
(100 %)
2 diff
(99.7 %id)
BP338161 Spleen .b 784 to 1364 1 to 579       579/579
(100 %)
2 diff
(99.7 %id)
AI719578 aorta .b 817 to 1033 217 to 1       217/219
(99 %)
3 diff
(98.7 %id)
AW247575 lung, small cell carcinoma .b 817 to 1317 7 to 507       501/507
(98 %)
8 diff
(98.5 %id)
BI116462 lung, small cell carcinoma .b 819 to 1603 1 to 797       797/843
(94 %)
40 diff
(95.3 %id)
BF303841 muscle, rhabdomyosarcoma .b 831 to 1542 1 to 722       722/1199
(60 %)
18 diff
(98.5 %id)
BF304879 muscle, rhabdomyosarcoma .b 831 to 1595 1 to 761       761/791
(96 %)
29 diff
(96.4 %id)
BF309837 muscle, rhabdomyosarcoma .b 832 to 1391 1 to 558       558/558
(100 %)
3 diff
(99.5 %id)
BI752377 brain .b 842 to 1465 1 to 623       623/623
(100 %)
3 diff
(99.6 %id)
TI_57218125   .b 842 to 1465 30 to 652       623/652
(95 %)
9 diff
(98.7 %id)
BE836670 prostate_normal .b 853 to 1274 423 to 3       421/423
(99 %)
1 diff
(99.8 %id)
BF958709 nervous_normal .b 882 to 1247 404 to 39       366/404
(90 %)
6 diff
(98.6 %id)
BF082662 breast .b 885 to 1170 71 to 356       286/363
(78 %)
12 diff
(96.7 %id)
BG949508 breast .b 885 to 1170 71 to 356       286/363
(78 %)
12 diff
(96.7 %id)
BG949559 breast .b 885 to 1170 71 to 356       286/363
(78 %)
12 diff
(96.7 %id)
BI035513 nervous_normal .b 895 to 1251 364 to 8       357/364
(98 %)
2 diff
(99.5 %id)
AA968984 Kidney, kidney tumor .b 895 to 1033 140 to 1       140/140
(100 %)
1 diff
(99.3 %id)
BF688302 eye, normal pigmented retinal epithelium .b 898 to 1563 1 to 668   fully sequenced,   668/668
(100 %)
3 diff
(99.6 %id)
CA393849 eye, RPE/choroid .b 899 to 1346 1 to 448       448/448
(100 %)
2 diff
(99.6 %id)
BE873762 large cell carcinoma, undifferentiated, lung .b 920 to 1523 1 to 620       593/620
(95 %)
18 diff
(97.1 %id)
BQ311825 breast_normal .b 933 to 1171 336 to 98       239/336
(71 %)
1 diff
(99.8 %id)
BF793810 adrenal cortex carcinoma, cell line, adrenal gland .b 936 to 1660 1 to 729       729/896
(81 %)
12 diff
(98.7 %id)
CN304469 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 945 to 1600 1 to 656       656/656
(100 %)
0 diff
(100 %id)
BE562693 endometrium, adenocarcinoma cell line, uterus .b 946 to 1666 1 to 721       721/881
(81 %)
11 diff
(98.8 %id)
BG327711 Kidney, renal cell adenocarcinoma .b 957 to 1636 1 to 678       678/678
(100 %)
4 diff
(99.5 %id)
BU186343 embryonal carcinoma, cell line, testis .b 964 to 1779 1 to 830       830/909
(91 %)
18 diff
(98.1 %id)
BP417746 small intestine .b 966 to 1390 29 to 453     Submitted on the opposite strand 425/453
(93 %)
6 diff
(98.7 %id)
DN994271 brain, whole brain .b 978 to 1619 6 to 647       642/647
(99 %)
6 diff
(99.1 %id)
BE218167 carcinoid, lung .b 988 to 1621 1 to 634     Submitted on the opposite strand 634/634
(100 %)
5 diff
(99.3 %id)
AA090212   .b 991 to 1127 1 to 137       137/137
(100 %)
6 diff
(95.7 %id)
AA091280   .b 991 to 1231 1 to 238       238/239
(99 %)
7 diff
(97.1 %id)
BQ894175 brain, neuroblastoma, cell line .b 1001 to 1782 1 to 783       783/865
(90 %)
10 diff
(98.9 %id)
BI045175 prostate_normal .b 1023 to 1376 18 to 371       354/379
(93 %)
10 diff
(97.4 %id)
BE082330 breast .b 1027 to 1298 14 to 285       272/285
(95 %)
6 diff
(97.9 %id)
BX429621 fetal liver, Liver .b 1049 to 1548 538 to 34       505/690
(73 %)
14 diff
(98.0 %id)
BP328433 rectum .b 1054 to 1564 1 to 511       511/581
(87 %)
7 diff
(98.8 %id)
BU172639 melanotic melanoma, skin .b 1056 to 1849 1 to 804       802/874
(91 %)
21 diff
(97.6 %id)
CB146394 Liver .b 1070 to 1556 1 to 487       487/487
(100 %)
6 diff
(98.8 %id)
W58262 heart .b 1072 to 1556 1 to 494       494/494
(100 %)
12 diff
(97.6 %id)
W58316 heart .b 1074 to 1557 1 to 489       489/489
(100 %)
9 diff
(98.2 %id)
BP221718 colon .b 1078 to 1647 1 to 570       570/570
(100 %)
4 diff
(99.3 %id)
BF881712.
matches multiple genes
lung_tumor .b 1088 to 1371 1 to 286   tiling clone, also hits gene BRD7P2 286/286
(100 %)
7 diff
(97.6 %id)
CN304467 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 1102 to 1697 9 to 604       596/604
(98 %)
9 diff
(98.6 %id)
BF925724 nervous_tumor .b 1109 to 1569 1 to 461       461/465
(99 %)
4 diff
(99.2 %id)
DR004197 Liver .b 1109 to 1771 1 to 662       662/662
(100 %)
4 diff
(99.4 %id)
CN304466 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 1111 to 1603 1 to 494       494/503
(98 %)
1 diff
(99.9 %id)
AA353892   .b 1112 to 1432 1 to 321       321/321
(100 %)
0 diff
(100 %id)
N84541   .b 1112 to 1354 1 to 230       230/230
(100 %)
21 diff
(90.9 %id)
BE378599 endometrium, adenocarcinoma cell line, uterus .b 1117 to 1917 1 to 805       805/1109
(72 %)
18 diff
(98.4 %id)
AW608786 pnet .b 1119 to 1474 359 to 2       358/359
(99 %)
0 diff
(100 %id)
AW875664 pnet .b 1119 to 1478 373 to 5       335/373
(89 %)
5 diff
(98.7 %id)
AW937976 denis_drash .b 1119 to 1531 413 to 1     Submitted on the opposite strand 413/413
(100 %)
0 diff
(100 %id)
BE075793 breast .b 1171 to 1384 12 to 223       213/234
(91 %)
10 diff
(95.8 %id)
BQ943439 brain, neuroblastoma, cell line .b 1239 to 2169 1 to 937       937/937
(100 %)
17 diff
(98.2 %id)
BE082301 breast .b 1330 to 1665 345 to 10     Submitted on the opposite strand 336/345
(97 %)
0 diff
(100 %id)
BF087341 head_neck .b 1348 to 1562 19 to 233       215/233
(92 %)
0 diff
(100 %id)
BQ923389 epidermoid carcinoma, cell line, lung .b 1429 to 2047 69 to 689       621/1178
(52 %)
17 diff
(98.6 %id)
TI_149297743   .b 1486 to 2292 881 to 80   AAA   802/948
(84 %)
9 diff
(99.1 %id)
BU627954 Bone, Enchondroma cell line .b 1516 to 2238 735 to 19   AAA   717/721
(99 %)
6 diff
(99.2 %id)
BF689092 eye, normal pigmented retinal epithelium .b 1533 to 2151 621 to 1   fully sequenced,   621/621
(100 %)
1 diff
(99.9 %id)
AA149392 uterus .b 1570 to 2058 1 to 510       510/520
(98 %)
33 diff
(93.7 %id)
AA149452.
matches multiple genes
uterus .b 1570 to 2048 1 to 489     also hits gene BRD7P2 489/505
(96 %)
17 diff
(96.7 %id)
BX093658 uterus .b 1572 to 2196 1 to 627       627/627
(100 %)
4 diff
(99.4 %id)
AI972132 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 1577 to 2238 660 to 1       660/660
(100 %)
6 diff
(99.1 %id)
BM982759 lung, Primary Lung Cystic Fibrosis EpithelialCells .b 1583 to 2292 729 to 19   AAA   711/711
(100 %)
1 diff
(99.9 %id)
BQ775912 Bone, Human Chondrosarcoma Cell Line .b 1603 to 2292 707 to 19   AAA   689/702
(98 %)
5 diff
(99.3 %id)
AW664039 pooled .b 1613 to 2240 637 to 10       628/637
(98 %)
2 diff
(99.7 %id)
TI_149281544   .b 1658 to 2299 659 to 19   AAA   641/799
(80 %)
13 diff
(98.4 %id)
TI_149304626   .b 1662 to 2299 723 to 86   AAA   638/955
(66 %)
2 diff
(99.8 %id)
BM971249 lung, Primary Lung Epithelial Cells .b 1662 to 2299 656 to 19   AAA   638/662
(96 %)
2 diff
(99.7 %id)
BE076320 breast .b 1663 to 2163 501 to 1     Submitted on the opposite strand 501/501
(100 %)
0 diff
(100 %id)
BM923291 pooled colon, kidney, stomach .b 1665 to 2240 8 to 583   AAA   576/1109
(51 %)
7 diff
(99.4 %id)
AW511083 pooled .b 1672 to 2240 564 to 2       563/567
(99 %)
13 diff
(97.8 %id)
BU596814 mixed (pool of 40 RNAs) .b 1684 to 2237 1 to 554       554/590
(93 %)
3 diff
(99.5 %id)
BM997264 lung, Metastatic Chondrosarcoma .b 1686 to 2218 549 to 19   AAA   531/531
(100 %)
2 diff
(99.7 %id)
AV742333 cord Blood .b 1693 to 2234 9 to 534   AAA   526/534
(98 %)
15 diff
(97.2 %id)
AW150117 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 1696 to 2298 618 to 17   AAA   602/602
(100 %)
8 diff
(98.7 %id)
AI699048 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 1703 to 2239 540 to 1       540/540
(100 %)
6 diff
(98.9 %id)
DB380503 placenta .b 1713 to 2238 524 to 1       524/602
(87 %)
16 diff
(97.4 %id)
AI016786   .b 1731 to 2238 520 to 13   AAA   508/508
(100 %)
1 diff
(99.9 %id)
W52222 senescent fibroblast .b 1739 to 2229 1 to 491       491/491
(100 %)
0 diff
(100 %id)
AW075996 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .b 1752 to 2292 567 to 27   AAA   541/542
(99 %)
7 diff
(98.8 %id)
CB854483 lung, Primary Lung Epithelial Cells .b 1758 to 2125 368 to 1       368/368
(100 %)
1 diff
(99.8 %id)
AA286943 germinal center B cell .b 1759 to 2238 492 to 13   AAA   480/480
(100 %)
0 diff
(100 %id)
AI934836 anaplastic oligodendroglioma, brain .b 1760 to 2219 460 to 1       460/463
(99 %)
0 diff
(100 %id)
AI150766 heart .b 1769 to 2240 475 to 4       472/475
(99 %)
0 diff
(100 %id)
AA488428   .b 1807 to 2292 508 to 23   AAA   486/486
(100 %)
0 diff
(100 %id)
BE328859 carcinoid, lung .b 1826 to 2114 289 to 1       289/307
(94 %)
3 diff
(99.1 %id)
W58174 heart .b 1828 to 2238 412 to 1       412/412
(100 %)
1 diff
(99.8 %id)
W58207 heart .b 1831 to 2238 409 to 1       409/409
(100 %)
1 diff
(99.8 %id)
BF827290 head_normal .b 1919 to 2027 12 to 119       108/134
(80 %)
3 diff
(97.8 %id)
AA583516   .b 1922 to 2238 324 to 8       317/331
(95 %)
0 diff
(100 %id)
AI025296   .b 1949 to 2298 355 to 6       350/355
(98 %)
0 diff
(100 %id)
AA961864 pooled germ cell tumors .b 1951 to 2240 290 to 1       290/290
(100 %)
0 diff
(100 %id)
BE536599 cervix .b 1952 to 2291 1 to 339       339/339
(100 %)
5 diff
(98.6 %id)
AA693807 liver and spleen .b 1953 to 2195 243 to 1       243/243
(100 %)
0 diff
(100 %id)
AA975938 carcinoid, lung .b 1953 to 2238 286 to 1       286/286
(100 %)
0 diff
(100 %id)
AI187188 lung .b 1953 to 2300 350 to 3       348/350
(99 %)
0 diff
(100 %id)
AA740455 2 pooled tumors (clear cell type), Kidney .b 1954 to 2304 354 to 4       351/354
(99 %)
0 diff
(100 %id)
AA948532 adenocarcinoma, colon .b 1955 to 2299 345 to 1       345/345
(100 %)
0 diff
(100 %id)
AI279780.
matches multiple genes
2 pooled tumors (clear cell type), Kidney .b 1959 to 2240 287 to 6     also hits gene BRD7P2 282/287
(98 %)
2 diff
(99.4 %id)
AI205814   .b 1960 to 2238 299 to 21   AAA   279/279
(100 %)
1 diff
(99.7 %id)
CD677718 eye, Trabecular meshwork .b 1977 to 2306 1 to 330   AAA   330/330
(100 %)
0 diff
(100 %id)
AA904242 carcinoid, lung .b 2004 to 2282 279 to 1       279/279
(100 %)
0 diff
(100 %id)
AA665763   .b 2014 to 2238 225 to 1       225/415
(54 %)
6 diff
(98.6 %id)
AI678946 Prostate .b 2030 to 2295 268 to 3       266/268
(99 %)
0 diff
(100 %id)
R76185 placenta .b 2035 to 2292 1 to 258   AAA   258/258
(100 %)
0 diff
(100 %id)
AW615116 pooled germ cell tumors .b 2048 to 2312 283 to 19   tiling clone, AAA   265/265
(100 %)
3 diff
(98.9 %id)
AI567647 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .b 2050 to 2240 192 to 2       191/192
(99 %)
0 diff
(100 %id)
AA670152 lung, lung carcinoma .b 2057 to 2239 183 to 1       183/183
(100 %)
0 diff
(100 %id)
AI358382 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .b 2079 to 2238 160 to 1       160/160
(100 %)
0 diff
(100 %id)
AI432410 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 2086 to 2222 160 to 24   AAA   137/137
(100 %)
1 diff
(99.3 %id)
AI129263 uterus .b 2097 to 2299 212 to 11   AAA   202/202
(100 %)
12 diff
(94.1 %id)
FN127021 breast carcinoma .b 2224 to 2297 74 to 3     Submitted on the opposite strand 72/75
(96 %)
0 diff
(100 %id)
BC001611 Brain, neuroblastoma .c 1 to 1499 1 to 1499 exact tiling clone, available from MGC, AAA   1499/1499
(100 %)
0 diff
(100 %id)
DA736879   .c 662 to 1410 2 to 750   capped   749/749
(100 %)
3 diff
(99.6 %id)
AW591138 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .c 1035 to 1561 532 to 4       529/549
(96 %)
13 diff
(97.7 %id)
AI191240 lung .c 1036 to 1499 481 to 18   AAA   464/464
(100 %)
0 diff
(100 %id)
BU752339 placenta .c 1039 to 1499 478 to 18   AAA   461/461
(100 %)
0 diff
(100 %id)
AI202807 anaplastic oligodendroglioma, brain .c 1044 to 1499 456 to 1       456/456
(100 %)
5 diff
(99.0 %id)
AI950064 anaplastic oligodendroglioma, brain .c 1044 to 1498 455 to 1       455/456
(99 %)
0 diff
(100 %id)
AA761218 germinal center B cell .c 1068 to 1499 452 to 20   AAA   433/433
(100 %)
15 diff
(96.6 %id)
AA634402   .c 1070 to 1501 442 to 7       436/442
(98 %)
5 diff
(98.9 %id)
AI809504 pooled .c 1071 to 1499 443 to 15   AAA   429/429
(100 %)
1 diff
(99.8 %id)
AI056857 liver and spleen .c 1073 to 1479 407 to 1       407/407
(100 %)
0 diff
(100 %id)
W03463 melanocyte .c 1075 to 1455 1 to 381       381/383
(99 %)
1 diff
(99.8 %id)
AA757744 pineal gland .c 1080 to 1500 419 to 1       419/419
(100 %)
2 diff
(99.6 %id)
AI299843 carcinoid, lung .c 1093 to 1501 413 to 5       409/413
(99 %)
0 diff
(100 %id)
AW072776 connective tissue, five pooled sarcomas, including myxoidliposarcoma, solitary fibrous tumor, malignant fibroushistiocytoma, gastrointestinal stromal tumor, andmesothelioma .c 1093 to 1553 472 to 12   AAA   461/461
(100 %)
2 diff
(99.6 %id)
AI290609 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 1098 to 1499 416 to 15   AAA   402/402
(100 %)
7 diff
(98.3 %id)
H80731 melanocyte .c 1102 to 1338 1 to 237       237/243
(97 %)
2 diff
(99.2 %id)
CF995275 Pooled Chondrosarcoma Tumor cells .c 1102 to 1507 74 to 480       407/516
(78 %)
11 diff
(97.9 %id)
AA553906 colon, tumor .c 1121 to 1456 336 to 1       336/346
(97 %)
0 diff
(100 %id)
AI356930 lymph node, lymphoma, follicular mixed small and largecell .c 1125 to 1501 380 to 4       377/380
(99 %)
2 diff
(99.5 %id)
H26607 breast .c 1126 to 1467 347 to 1     Submitted on the opposite strand 347/347
(100 %)
9 diff
(97.5 %id)
N28926 melanocyte .c 1136 to 1670 1 to 544       544/547
(99 %)
16 diff
(97.1 %id)
D12468 Liver .c 1140 to 1493 1 to 355       355/358
(99 %)
10 diff
(97.3 %id)
AI571814 anaplastic oligodendroglioma, brain .c 1148 to 1499 352 to 1       352/352
(100 %)
0 diff
(100 %id)
CA455530 mixed (pool of 40 RNAs) .c 1150 to 1569 1 to 426       426/827
(51 %)
8 diff
(99.1 %id)
AA723431 heart .c 1154 to 1559 401 to 2       400/401
(99 %)
5 diff
(98.8 %id)
AI304684 adenocarcinoma, colon .c 1167 to 1560 394 to 1       394/394
(100 %)
0 diff
(100 %id)
AA952923 pooled .c 1168 to 1499 331 to 1       331/331
(100 %)
1 diff
(99.7 %id)
AI917786 pooled germ cell tumors .c 1175 to 1554 383 to 4       380/383
(99 %)
0 diff
(100 %id)
T94477 lung .c 1207 to 1456 1 to 253       253/261
(96 %)
8 diff
(97.0 %id)
DA356678 subthalamic nucleus .c 1352 to 1924 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
CN272078 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 1419 to 2043 9 to 633   tiling clone,   625/633
(98 %)
6 diff
(99.1 %id)
BF246747 brain, glioblastoma .c 1448 to 2115 1 to 658       658/862
(76 %)
41 diff
(95.3 %id)
BF695540 brain, primitive neuroectoderm .c 1448 to 2132 1 to 682       682/875
(77 %)
17 diff
(98.1 %id)
R13698 whole brain .c 1483 to 1825 1 to 347       347/347
(100 %)
5 diff
(98.6 %id)
H61744 liver and spleen .c 1532 to 1873 1 to 349     Submitted on the opposite strand 349/349
(100 %)
8 diff
(97.8 %id)
H90400 liver and spleen .c 1532 to 1869 1 to 339     Submitted on the opposite strand 339/346
(97 %)
5 diff
(98.6 %id)
AW793558 uterus .c 1541 to 1710 1 to 169       169/169
(100 %)
2 diff
(98.9 %id)
CV400185 head_neck .c 1564 to 1679 135 to 20     Submitted on the opposite strand 116/135
(85 %)
0 diff
(100 %id)
FN131675 breast carcinoma .c 1573 to 1668 96 to 1     Submitted on the opposite strand 96/96
(100 %)
0 diff
(100 %id)
N43948 multiple sclerosis lesions .c 1607 to 1863 1 to 257       257/257
(100 %)
0 diff
(100 %id)
BF576656 muscle (skeletal) .c 1616 to 2298 1 to 681       681/862
(79 %)
21 diff
(97.6 %id)
BX362440   .c 1690 to 2540 855 to 1       855/855
(100 %)
25 diff
(97.1 %id)
W55899 heart .c 1765 to 2113 1 to 352   fully sequenced,   352/352
(100 %)
4 diff
(98.9 %id)
BX471219   .c 1806 to 2207 1 to 406       406/406
(100 %)
5 diff
(98.8 %id)
AL703762 human skeletal muscle .c 1917 to 2415 1 to 501   tiling clone,   501/501
(100 %)
5 diff
(99.1 %id)
DA313695 hippocampus .c 1928 to 2356 2 to 430   capped   429/429
(100 %)
1 diff
(99.8 %id)
BX374057   .c 2009 to 2589 584 to 1       584/798
(73 %)
23 diff
(97.2 %id)
AI131537 heart .c 2018 to 2593 577 to 1       577/577
(100 %)
2 diff
(99.7 %id)
AW872895 squamous cell carcinoma, tongue .c 2031 to 2455 431 to 7       425/431
(98 %)
0 diff
(100 %id)
N21496 melanocyte .c 2053 to 2593 540 to 1       540/542
(99 %)
5 diff
(99.1 %id)
BF002941 Prostate .c 2058 to 2593 553 to 14   AAA   540/540
(100 %)
2 diff
(99.7 %id)
N34874 multiple sclerosis lesions .c 2073 to 2459 387 to 1       387/392
(98 %)
0 diff
(100 %id)
W55900 heart .c 2083 to 2598 519 to 1   fully sequenced,   519/519
(100 %)
5 diff
(99.1 %id)
AI809526 pooled .c 2122 to 2663 553 to 12   AAA   542/542
(100 %)
3 diff
(99.5 %id)
AI191908   .c 2153 to 2598 447 to 2       446/447
(99 %)
0 diff
(100 %id)
N67863 melanocyte .c 2158 to 2593 440 to 1       440/460
(95 %)
7 diff
(98.5 %id)
AI769348 pooled .c 2162 to 2593 444 to 13   AAA   432/432
(100 %)
1 diff
(99.8 %id)
AI240914 Kidney .c 2163 to 2593 431 to 1       431/431
(100 %)
0 diff
(100 %id)
BG027473 Bone, osteosarcoma, cell line .c 2187 to 2945 11 to 754       744/809
(91 %)
12 diff
(98.6 %id)
H80732 melanocyte .c 2205 to 2582 379 to 1       379/392
(96 %)
1 diff
(99.8 %id)
AA912894 pooled .c 2213 to 2663 452 to 1   tiling clone,   452/452
(100 %)
1 diff
(99.8 %id)
FN155127 breast carcinoma .c 2287 to 2416 1 to 129       129/130
(99 %)
2 diff
(98.5 %id)
N25720.
matches multiple genes
melanocyte .c 2320 to 2594 276 to 2     also hits gene C1orf198 275/276
(99 %)
0 diff
(100 %id)
BE843899 testis_normal .c 2337 to 2597 1 to 262       262/262
(100 %)
9 diff
(96.6 %id)
T94389 lung .c 2345 to 2572 229 to 1       229/229
(100 %)
1 diff
(99.6 %id)
BQ951888 leiomyosarcoma, uterus .c 2440 to 2593 1 to 154   AAA   154/154
(100 %)
0 diff
(100 %id)
BG230837 nasopharynx, normal epithelium .c 2448 to 2621 41 to 214       174/214
(81 %)
6 diff
(97.2 %id)
D20575   .c 2456 to 2553 98 to 1       98/98
(100 %)
0 diff
(100 %id)
BM144270 leukopheresis .c 2456 to 2820 15 to 379   AAA   365/379
(96 %)
6 diff
(98.5 %id)
BM145118 leukopheresis .c 2456 to 2804 15 to 363       349/363
(96 %)
7 diff
(98.1 %id)
AA283447   .c 2468 to 2706 1 to 231       231/231
(100 %)
12 diff
(94.9 %id)
BE548951 cervical carcinoma cell line, cervix .c 2481 to 3034 1 to 550       550/604
(91 %)
11 diff
(98.2 %id)
AI765875 Kidney .c 2492 to 3027 536 to 1       536/536
(100 %)
2 diff
(99.7 %id)
AV699243 hepatocellular carcinoma .c 2535 to 3027 1 to 492   AAA   492/492
(100 %)
1 diff
(99.8 %id)
D56773   .c 2577 to 2890 1 to 313       313/315
(99 %)
3 diff
(99.1 %id)
FN052651 breast carcinoma .c 2593 to 2673 1 to 81       81/82
(98 %)
1 diff
(98.8 %id)
BE180001 head_neck .c 2595 to 3041 1 to 446   tiling clone,   446/446
(100 %)
6 diff
(98.7 %id)
DB369449   .c 2607 to 3033 457 to 29   AAA   429/434
(98 %)
4 diff
(99.1 %id)
AW580839 leiomios .c 2608 to 3251 1 to 640       640/640
(100 %)
16 diff
(97.5 %id)
CN277191 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 2646 to 3406 1 to 764       764/764
(100 %)
5 diff
(99.4 %id)
N52042 multiple sclerosis lesions .c 2654 to 3027 379 to 1       379/391
(96 %)
7 diff
(98.3 %id)
BM543987 ovary (pool of 3) .c 2691 to 3683 1 to 1005   tiling clone,   1005/1045
(96 %)
37 diff
(96.5 %id)
BU944966 mixed (pool of 40 RNAs) .c 2809 to 2950 1 to 142   AAA   142/142
(100 %)
4 diff
(97.2 %id)
FN108235 breast carcinoma .c 3190 to 3292 1 to 102       102/102
(100 %)
1 diff
(99.1 %id)
DB069497 testis .c 3272 to 3815 2 to 545   tiling clone, capped   544/544
(100 %)
2 diff
(99.7 %id)
BM690847 eye, Retina Foveal and Macular .c 3615 to 4111 7 to 503   tiling clone, fully sequenced,   497/503
(98 %)
4 diff
(99.3 %id)
BQ368385 placenta_normal .c 3647 to 3967 22 to 342       321/342
(93 %)
6 diff
(98.3 %id)
FN114920 breast carcinoma .c 3655 to 3759 1 to 106       106/106
(100 %)
1 diff
(99.1 %id)
BQ368624 placenta_normal .c 3664 to 3863 1 to 203       203/208
(97 %)
8 diff
(96.2 %id)
FN171624 breast carcinoma .c 3683 to 3785 1 to 106       106/107
(99 %)
5 diff
(95.4 %id)
BU622055 Cell Line, Chondrosarcoma .c 3789 to 4514 738 to 13   AAA   726/726
(100 %)
2 diff
(99.8 %id)
BX506586 Liver .c 3922 to 4644 1 to 723       723/723
(100 %)
3 diff
(99.6 %id)
CD610774   .c 4012 to 4634 1 to 623       623/639
(97 %)
3 diff
(99.6 %id)
BQ336186 marrow .c 4024 to 4305 1 to 284       284/284
(100 %)
8 diff
(97.2 %id)
BM663726 eye, Retina Foveal and Macular .c 4081 to 4524 461 to 18   tiling clone, fully sequenced, AAA   444/444
(100 %)
0 diff
(100 %id)
DA533239 brain .c 4427 to 4994 2 to 569   tiling clone, capped   568/568
(100 %)
0 diff
(100 %id)
BE866917 adenocarcinoma, colon .c 4441 to 5097 1 to 647   tiling clone,   647/928
(69 %)
18 diff
(98.1 %id)
CN304470 embryonic stem cells, DMSO-treated H9 cellline .d 1 to 437 11 to 447   tiling clone,   437/438
(99 %)
5 diff
(98.9 %id)
AV747130 Pituitary .d 373 to 924 1 to 545   tiling clone,   545/551
(98 %)
7 diff
(98.8 %id)
TI_57189689   .d 377 to 1187 54 to 863       810/810
(100 %)
9 diff
(98.9 %id)
BI860548 breast, mammary adenocarcinoma, cell line .d 378 to 1187 1 to 809   tiling clone,   809/809
(100 %)
9 diff
(98.9 %id)
R87444 brain .d 1033 to 1377 1 to 348   tiling clone,   348/348
(100 %)
4 diff
(98.9 %id)
BM686908 eye, optic nerve .d 1296 to 1869 9 to 582   tiling clone,   574/582
(98 %)
6 diff
(99.0 %id)
AA214465   .d 1415 to 1805 1 to 399       399/400
(99 %)
21 diff
(94.8 %id)
CR740401 ovarian tumor, ovary .d 1493 to 2158 1 to 666       666/666
(100 %)
1 diff
(99.9 %id)
AA464111 ovarian tumor, ovary .d 1495 to 1912 13 to 431       419/431
(97 %)
6 diff
(98.7 %id)
BM930227 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 1569 to 2236 1 to 669       669/669
(100 %)
1 diff
(99.9 %id)
TI_154197850   .d 1667 to 2359 44 to 735       692/1060
(65 %)
46 diff
(95.7 %id)
TI_154196218   .d 1690 to 2345 16 to 670       655/1027
(63 %)
13 diff
(98.8 %id)
BU742219 eye, fetal eye .d 1744 to 2388 663 to 19   tiling clone, AAA   645/645
(100 %)
0 diff
(100 %id)
CU454945 epidermis .d 1798 to 2284 21 to 507       487/517
(94 %)
2 diff
(99.7 %id)
AA604396 adrenal adenoma, adrenal gland .d 1828 to 2408 581 to 1       581/581
(100 %)
3 diff
(99.5 %id)
BQ011126 placenta .d 1918 to 2394 489 to 13   AAA   477/477
(100 %)
0 diff
(100 %id)
BE222661 brain, oligodendroglioma .d 1969 to 2397 430 to 2       429/430
(99 %)
0 diff
(100 %id)
AA463976 ovarian tumor, ovary .d 1986 to 2394 408 to 1       408/408
(100 %)
1 diff
(99.8 %id)
BQ010763 placenta .d 2029 to 2394 377 to 12   AAA   366/366
(100 %)
1 diff
(99.8 %id)
R87445 brain .d 2058 to 2380 328 to 3       326/331
(98 %)
0 diff
(100 %id)
AA214369   .d 2062 to 2441 401 to 23   tiling clone, AAA   379/380
(99 %)
1 diff
(99.8 %id)
AI024322   .d 2064 to 2409 350 to 5       346/350
(98 %)
0 diff
(100 %id)
AW514132 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 2123 to 2409 292 to 6       287/292
(98 %)
0 diff
(100 %id)
BM673111 eye, optic nerve .d 2131 to 2388 276 to 19   AAA   258/258
(100 %)
3 diff
(98.9 %id)
CF529101 placenta .d 2170 to 2394 242 to 18   AAA   225/225
(100 %)
1 diff
(99.6 %id)
AI690000 carcinoid, lung .d 2231 to 2394 188 to 25   AAA   164/164
(100 %)
0 diff
(100 %id)
DA735034   .e 1 to 794 2 to 801   tiling clone, capped   800/857
(93 %)
22 diff
(97.5 %id)
TI_149285524   .e 656 to 1426 849 to 89   tiling clone, AAA   761/1073
(70 %)
14 diff
(98.7 %id)
BM984939 lung .e 792 to 1426 653 to 19   AAA   635/635
(100 %)
0 diff
(100 %id)
DB367200   .e 1997 to 2524 523 to 1   tiling clone,   523/523
(100 %)
15 diff
(97.2 %id)
AA383502 testis .f 1 to 259 1 to 259   tiling clone,   259/259
(100 %)
1 diff
(99.7 %id)
BG751851 eye, normal pigmented retinal epithelium .f 125 to 915 1 to 790       790/834
(94 %)
14 diff
(98.4 %id)
TI_149279818   .f 156 to 913 795 to 35   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 761/1237
(61 %)
16 diff
(98.8 %id)
BM803815 leiomyosarcoma, uterus .f 214 to 939 33 to 763       731/1110
(65 %)
17 diff
(98.5 %id)
TI_149305717   .f 216 to 913 767 to 70   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 698/1081
(64 %)
0 diff
(100 %id)
BU686027 lung, Primary Lung Epithelial Cells .f 216 to 913 698 to 1   tiling clone,   698/708
(98 %)
4 diff
(99.5 %id)
BX326100 Placenta Cot 25-normalized .f 462 to 1019 594 to 37       558/857
(65 %)
17 diff
(98.1 %id)
BX377621 Placenta Cot 25-normalized .f 830 to 1868 1041 to 1   tiling clone,   1041/1041
(100 %)
4 diff
(99.7 %id)
BX333664 Neuroblastoma Cot 25-normalized .g 1 to 623 1 to 623   tiling clone, fully sequenced,   623/623
(100 %)
0 diff
(100 %id)
BX333663 Neuroblastoma Cot 25-normalized .g 562 to 1382 827 to 1   tiling clone, fully sequenced,   827/827
(100 %)
32 diff
(96.2 %id)
BQ001490 lung, Metastatic Chondrosarcoma .h 1 to 675 676 to 1 K19T L43V Q192T S193E G194W ... tiling clone,   676/676
(100 %)
3 diff
(99.6 %id)
AW957737   .i 1 to 436 1 to 436 L84S L110V S126R M131I Q141H ... tiling clone,   436/549
(79 %)
7 diff
(98.8 %id)
BM847788 myeloma .j 1 to 546 1 to 546 L10M tiling clone,   546/546
(100 %)
2 diff
(99.7 %id)
BX111474 Kidney .k-u 1 to 452 1 to 451   tiling clone,   451/458
(98 %)
2 diff
(99.6 %id)
BM908958 astrocytoma grade IV, cell line, brain .k-u 239 to 1033 1 to 802       802/1120
(71 %)
36 diff
(96.8 %id)
AI433530 Kidney .k-u 318 to 854 537 to 1   tiling clone,   537/537
(100 %)
0 diff
(100 %id)
BE764716 nervous_tumor .k-u 491 to 776 1 to 283       283/283
(100 %)
5 diff
(98.3 %id)
BM728440 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .k-u 619 to 1216 1 to 597 Q83R T84P tiling clone,   597/597
(100 %)
2 diff
(99.7 %id)
CV572183 cornea, eye .l-u 1 to 620 1 to 620 exact tiling clone,   620/620
(100 %)
1 diff
(99.9 %id)
N67592 cochlea, ear .l-u 589 to 1004 414 to 1   tiling clone,   414/414
(100 %)
1 diff
(99.8 %id)
AW835746 leiomios .m-u 1 to 492 27 to 517   tiling clone,   491/517
(94 %)
6 diff
(98.9 %id)
AA360890   .m-u 395 to 608 214 to 1 H2Y N9X R27X I41X tiling clone, Submitted on the opposite strand 214/215
(99 %)
1 diff
(99.6 %id)
AI282542 lymph node, mantle cell lymphoma .n-u 1 to 419 432 to 14 exact tiling clone, AAA   419/419
(100 %)
0 diff
(100 %id)
AA134321.
matches multiple genes
  P2.a-u 169 to 574 1 to 422     also hits gene BRD7P2 422/427
(98 %)
29 diff
(93.3 %id)
DB000442.
matches multiple genes
breast, tumor tissue P2.a-u 276 to 783 35 to 545   capped also hits gene BRD7P2 511/544
(93 %)
0 diff
(100 %id)
AW369759.
matches multiple genes
breast P2.a-u 383 to 864 107 to 590     also hits gene BRD7P2 484/592
(81 %)
10 diff
(98.4 %id)
BF881712.
matches multiple genes
lung_tumor P2.a-u 1058 to 1341 1 to 286   tiling clone, also hits gene BRD7P2 286/286
(100 %)
6 diff
(98.0 %id)
BM699212.
matches multiple genes
eye, fetal eyes P2.a-u 1385 to 1953 1 to 568   tiling clone, also hits gene BRD7P2 568/570
(99 %)
16 diff
(97.2 %id)
AA151589.
matches multiple genes
uterus P2.b 1437 to 1989 560 to 1     also hits gene BRD7P2 560/561
(99 %)
18 diff
(96.8 %id)
AI279780.
matches multiple genes
2 pooled tumors (clear cell type), Kidney P2.b 1726 to 2012 287 to 1     also hits gene BRD7P2 287/287
(100 %)
6 diff
(98.0 %id)
BC050728 Skin, melanotic melanoma. Gene BRD7, variant not shown       available from MGC, AAA This clone was ignored    
BC094706 Brain, cerebellar cortex Gene BRD7, variant not shown       AAA Suspected internal deletion, this clone was ignored    
DB312751 thalamus Gene BRD7, variant not shown         This clone was ignored    
DA416025 thalamus Gene BRD7, variant not shown       capped This clone was ignored    
AV656419 corresponding non cancerous liver tissue Gene BRD7, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
BF317445 brain, neuroblastoma Gene BRD7, variant not shown              
BI199329 brain, neuroblastoma Gene BRD7, variant not shown              
BU193924 melanotic melanoma, skin Gene BRD7, variant not shown         This clone was ignored    
CD300112 testis Gene BRD7, variant not shown         This clone was ignored    
CK003733 brain/CNS, Human Brain - Cerebellar Cortex Gene BRD7, variant not shown         Suspected internal deletion, this clone was ignored    
CA312534 Human Lung Epithelial cells, lung Gene BRD7, variant not shown       AAA Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k-u, .l-u, .m-u, .n-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI